期刊文献+

交叉反应组配型在高致敏患者肾移植中的应用 被引量:7

Clinical use of cross reactive groups matching in highly sensitized recipients of kidney recipients
原文传递
导出
摘要 目的 探讨交叉反应组 (CREG)配型在高致敏患者肾移植中的临床意义。方法 动态监测肾移植受者体内群体反应性抗体 (PRA)的水平及其特异性 ,按照CREG配型原则选择最匹配的供者。结果  6 0例受者术前PRA超过 11% ,均有单纯性或混合性升高 ;按照CREG配型 ,0~ 1个抗原错配、2个抗原错配、3~ 4个抗原错配者术后肌酐恢复正常的时间平均为 6 .5d、7.0d、12 .7d ,发生肾功能恢复延迟的例数分别为 0、7例、3例 ,各组间的差异具有显著性 (P <0 .0 5 )。结论 高致敏受者在肾移植时采用CREG配型 ,可避开受者预存的HLA抗体特异性所对应的抗原 ,对于提高肾移植人 Objective To investigate the clinical significance of cross reactive groups (CREG) matching in highly sensitized recipients of kidney recipients by testing their serum PRA levels and specificity.Methods The dynamic PRA levels and the specificity were determined. CREG matching was used to select the best donors. Results The preoperative PRA levels in 60 kidney recipients heightened simply or mixedly. Acccording to CREG matching with 0 to 1 MM, 2 MM and 3 to 4 MM, the average recovery time of postoperative creatinine was 6.5 , 7.0 and 12.7 days respectively and the number of the patients with delayed graft function was 0, 7 and 3 respectively.Conclusion There was a great applied value to raise survival rate of patients or allografts for highly sensitized recipients of kidney recipients by CREG matching, to select donors with compatible HLA phenotype or more compatible, to shun the specific antigen of pre existing HLA antibody in recipients and to strictly prohibit HLA repeat mismatches for those retransplantation recipients.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2003年第3期143-144,共2页 Chinese Journal of Organ Transplantation
关键词 肾移植术 HLA交叉反应组配型原则 群体反应性抗体 酶联免疫吸附分析法 Immunization Kidney transplantation Histocompatibility testing Antibody specificity
  • 相关文献

参考文献5

  • 1谭建明,谢桐,徐琴君,徐达,王祥慧,丁言德.PCR-SSP快速HLA-DR基因分型与临床应用[J].中华外科杂志,1996,34(1):4-6. 被引量:11
  • 2王庆华,谭建明,吴卫真.HLA配型在肾移植中的临床应用[J].临床泌尿外科杂志,1999,14(5):193-194. 被引量:5
  • 3Speiser DE, Jeannet M. Renal transplantation to mnsitized patient:decreased graft survival probability associated with a positive historical crossmatch. Transplant Immunol, 1995, 3:330-338.
  • 4Moore SB, Ploeger NA, DeGoey SR. HLA antibody acreening.Transplantation, 1997, 64:1617-1620.
  • 5Cole E, Naimark D, Aprile M, et al. An analysis for prodictors of longterm cadaveric renal allograft survival. Clin Transplant, 1995,9: 282-289.

二级参考文献5

  • 1谭建明,谢桐,徐琴君,张先有,徐达,王祥慧,丁言德.顺序特异引物聚合酶链反应技术HLA-DR1,DR51组的基因快速分型[J].上海医科大学学报,1996,23(3):195-195. 被引量:4
  • 2谭建明 谢桐 等.PCR-SSP快速ALA-DR基因分型与临床应用[J].中华外科杂志,1996,34:4-6.
  • 3谭建明.HLA配型在肾酰中的临床意义[J].国外医学:泌尿系统分册,1995,15:23-23.
  • 4谭建明,国外医学泌尿系统分册,1995年,15卷,23页
  • 5谭建明,国外医学泌尿系统分册,1994年,14卷,211页

共引文献11

同被引文献68

  • 1谭建明,谢桐,徐琴君,徐达,王祥慧,丁言德.PCR-SSP快速HLA-DR基因分型与临床应用[J].中华外科杂志,1996,34(1):4-6. 被引量:11
  • 2孙启全.肾移植致敏受者处理措施的选择[J].肾脏病与透析肾移植杂志,2006,15(6):538-539. 被引量:8
  • 3陆再英,钟南山.内科学.第七版.北京:人民卫生出版社.2008:783-784.
  • 4McKenna RM,Takemoto SK,Terasaki PL Anti-HLA antibodies after solid organ transplantation.Transplantation,2000,69(3):319-326.
  • 5Terasaki PI.Humoral theory of transplantation.Am J Transplant,2003,3(6):665-673.
  • 6Gebel HM,Bray RA,Nickerson P.Pre-transplant assessment of donor-reactive,HLA-specific antibodies in renal transplantation:Contraindication vs.risk.Am J Transplant,2003,3(12):1488-1500.
  • 7Moll S,Pascual M.Humoral rejection of organ allografts.Am J Transplant,2005,5 (11):2611-2618.
  • 8Cai J,Terasaki PL Humoral theory of transplantation.Mechanism,prevention,and treatment.Hum Immunol,2005,66(4):334-342.
  • 9Terasaki PI,Ozawa M.Predicting kidney graft failure by HLA antibodies:a prospective trial.Am J Transplant,2004,4(3):438-443.
  • 10Lee PC,Terasaki PI,Takemoto SK,et al.All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies.Transplantation,2002,74(8):1192-1194.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部